Article Information
History
- October 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Mi-Hyang Jung, MD, PhD1,*,
- Dong-Hyuk Cho, MD, PhD2,*,
- Jimi Choi, PhD3,
- Mi-Na Kim, MD, PhD2,
- Chan Joo Lee, MD, PhD4,
- Jung-Woo Son, MD5,
- Jong-Chan Youn, MD, PhD1,† and
- Byung-Su Yoo, MD, PhD5,†
- 1Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 2Division of Cardiology, Department of Internal Medicine, Korea University Medicine, Seoul, Republic of Korea
- 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Medicine, Seoul, Republic of Korea
- 4Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
- 5Division of Cardiology, Department of Internal Medicine, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea
- ↵†Corresponding authors: Jong-Chan Youn, MD, PhD,
Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. Telephone: +82-2-2258-6145; Fax: +82-2-591-1506; Email: jong.chan.youn{at}gmail.com, Byung-Su Yoo, MD, PhD
, Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University, 20, Ilsan-ro, Wonju, Gangwon-do 26426, Republic of Korea, Telephone: +82-33-741-0917; Fax: +82-33-741-1219; E-mail: yubs{at}yonsei.ac.kr
↵* The authors made equal contributions to this work and are designated as first authors.
Posted October 15, 2024.
Association Between Angiotensin Receptor-Neprilysin Inhibitor Use and Clinical Outcomes in Concurrent Heart Failure with Reduced Ejection Fraction and End-Stage Renal Disease
